Decrease methotrexate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases17

Arthritis, Rheumatoid Leukemia L1210 Precursor Cell Lymphoblastic Leukemia-Lymphoma Pregnancy, Ectopic Osteosarcoma Leukemia, Lymphoid Central Nervous System Neoplasms Pregnancy, Tubal Sarcoma 180 Psoriasis Gestational Trophoblastic Disease Mucositis Carcinoma, Ehrlich Tumor Arthritis, Juvenile Arthritis, Psoriatic Trophoblastic Neoplasms Leukemia L5178

Chemicals and Drugs40

Methotrexate Polyglutamic Acid Antirheumatic Agents Folic Acid Antagonists Tetrahydrofolate Dehydrogenase Aminopterin Antimetabolites, Antineoplastic Reduced Folate Carrier Protein Trimetrexate Folic Acid gamma-Glutamyl Hydrolase Leucovorin Tetrahydrofolates Abortifacient Agents, Nonsteroidal Cyclophosphamide Immunosuppressive Agents Sulfasalazine Vincristine Deoxyuridine 6-Mercaptopurine Dermatologic Agents Fluorouracil Formyltetrahydrofolates Folate Receptors, GPI-Anchored Doxorubicin Phosphoribosylaminoimidazolecarboxamide Formyltransferase Prednisone Cytarabine Thymidylate Synthase Hydroxychloroquine Pteroylpolyglutamic Acids Isoxazoles Asparaginase Hydroxymethyl and Formyl Transferases Probenecid Nucleotide Deaminases Vinblastine Antibodies, Monoclonal Cisplatin Hypoxanthines

Analytical, Diagnostic and Therapeutic Techniques and Equipment9

Drug Therapy, Combination Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Injections, Spinal Remission Induction Double-Blind Method Combined Modality Therapy Administration, Oral

Phenomena and Processes4

Drug Resistance Dose-Response Relationship, Drug Biological Transport Time Factors

Health Care2

Treatment Outcome Double-Blind Method

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care

Methotrexate Polyglutamic Acid Antirheumatic Agents Folic Acid Antagonists Tetrahydrofolate Dehydrogenase Arthritis, Rheumatoid Aminopterin Antimetabolites, Antineoplastic Leukemia L1210 Reduced Folate Carrier Protein Trimetrexate Folic Acid gamma-Glutamyl Hydrolase Drug Therapy, Combination Leucovorin Tetrahydrofolates Abortifacient Agents, Nonsteroidal Cyclophosphamide Drug Resistance Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Immunosuppressive Agents Sulfasalazine Vincristine Deoxyuridine Precursor Cell Lymphoblastic Leukemia-Lymphoma Drug Administration Schedule 6-Mercaptopurine Dermatologic Agents Pregnancy, Ectopic Fluorouracil Formyltetrahydrofolates Folate Receptors, GPI-Anchored Doxorubicin Phosphoribosylaminoimidazolecarboxamide Formyltransferase Osteosarcoma Injections, Spinal Prednisone Dose-Response Relationship, Drug Cytarabine Thymidylate Synthase Leukemia, Lymphoid Hydroxychloroquine Central Nervous System Neoplasms Pregnancy, Tubal Sarcoma 180 Pteroylpolyglutamic Acids Isoxazoles Psoriasis Asparaginase Gestational Trophoblastic Disease Remission Induction Biological Transport Hydroxymethyl and Formyl Transferases Probenecid Mucositis Nucleotide Deaminases Carcinoma, Ehrlich Tumor Double-Blind Method Vinblastine Antibodies, Monoclonal Arthritis, Juvenile Combined Modality Therapy Arthritis, Psoriatic Trophoblastic Neoplasms Time Factors Administration, Oral Leukemia L5178 Cisplatin Hypoxanthines

No FAQ available that match "decrease methotrexate"